FI
STIM icon

FormulaFolio Investments’s Neuronetics STIM Stock Holding History

FormulaFolio Investments’s Portfolio STIM Stock Details STIM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		$3K Hold
213
– – ﹤0.01% 414
2021
Q1 		$3K Buy
+213
New +$3.27K ﹤0.01% 384

Other funds holding STIM

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
ACM
Archon Capital Management Seattle, Washington $177M AUM 108.05% 1-Year Est. Return
CC
Cannell Capital Alta, Wyoming $163M AUM 40.62% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
KLC
Kent Lake Capital Reno, Nevada $222M AUM 18.04% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

FormulaFolio Investments's STIM Position: Q2 2021 in Review

FormulaFolio Investments held its Neuronetics (STIM) position steady in Q2 2021 at 213 shares worth $3K. The position accounts for ﹤0.01% of the portfolio, ranked #414.

FormulaFolio Investments first reported a position in STIM in Q1 2021 and has held it in 2 quarters since. 105 funds tracked by Wall St. Rank hold STIM as of Q2 2021.

  • FormulaFolio Investments held 213 shares of Neuronetics worth $3K as of Q2 2021.
  • FormulaFolio Investments left its Neuronetics share count unchanged in Q2 2021.
  • Neuronetics made up ﹤0.01% of FormulaFolio Investments's portfolio in Q2 2021, its #414 holding.
  • FormulaFolio Investments first reported a position in Neuronetics in Q1 2021 and has held it in 2 quarters since.
  • 105 funds tracked by Wall St. Rank held Neuronetics as of Q2 2021.

Based on FormulaFolio Investments's 13F filing for Q2 2021, filed 28 Jul 2021.